ORIGINAL RESEARCH article
Front. Med.
Sec. Dermatology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1655302
Personalized Prediction Model for Scar Response After Radionuclide Therapy: Development and Validation in a Chinese Cohort
Provisionally accepted
- Fujian Medical University Union Hospital, Fuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Scarring represents a persistent clinical and psychosocial challenge, with considerable variability in treatment response among patients. While both clinical and morphologic factors can influence outcomes, robust, individualized prediction of scar treatment efficacy remains elusive. Objective: To develop and validate an integrated predictive model for scar treatment outcomes using a combination of clinical and image-derived features in a Chinese cohort, and to translate this model into a web-based calculator for practical clinical application. This model requires validation in other ethnicities. Methods: We retrospectively analyzed 117 Chinese patients with scars treated at a single center, dividing them into a training (n=83) and validation cohort (n=34). Clinical data (including age, scar height) and quantitative features extracted from standardized scar photographs (solidity and mean saturation [S_mean]) were used to construct clinical, image-based, and combined predictive models. Feature selection was performed via LASSO regression, and models were developed using multivariate logistic regression. Model performance was evaluated using area under the receiver operating characteristic curve (AUC), calibration metrics (Brier score, log loss, HL test), and decision curve analysis (DCA). Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated. A user-friendly web calculator was subsequently developed. Results: Scar height and age (clinical factors) as well as solidity and S_mean (image-derived metrics) were identified as independent predictors of poor treatment outcome. The combined model demonstrated superior discrimination (AUC 0.970 [training], 0.908 [test]), calibration, and clinical utility compared to clinical or image-based models alone. Calibration curves and metrics indicated excellent agreement between predicted and observed probabilities for the combined model. DCA, NRI, and IDI analyses further highlighted the incremental value and net benefit of the integrated approach. A web-based calculator was developed to enable individualized outcome prediction and support clinical decision-making. Conclusion: Integration of clinical and image-derived features enables robust, individualized prediction of scar treatment outcomes in this Chinese cohort. Our validated combined model, accessible via an easy-to-use web-based calculator, may enhance treatment planning, risk stratification, and patient counseling in scar management. Validation in diverse ethnic populations is essential.
Keywords: SCARs, prediction, image analysis, Clinical features, Web calculator
Received: 30 Jun 2025; Accepted: 29 Sep 2025.
Copyright: © 2025 Su, Chen, Wang, Song, Xu, Lin and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jin Zhao Su, 13365912227@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.